These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
88 related articles for article (PubMed ID: 2392061)
1. High-density lipoprotein response to 5-alpha-dihydrotestosterone and testosterone in Macaca fascicularis: a hormone-responsive primate model for the study of atherosclerosis. Greger NG; Insull W; Probstfield JL; Keenan BS Metabolism; 1990 Sep; 39(9):919-24. PubMed ID: 2392061 [TBL] [Abstract][Full Text] [Related]
2. Testosterone and its metabolites in male cynomolgus monkeys (Macaca fascicularis): behavior and biochemistry. Michael RP; Bonsall RW; Zumpe D Physiol Behav; 1987; 40(4):527-37. PubMed ID: 3628550 [TBL] [Abstract][Full Text] [Related]
3. Comparison of the effects of testosterone and dihydrotestosterone on the behavior of male cynomolgus monkeys (Macaca fascicularis). Michael RP; Zumpe D; Bonsall RW Physiol Behav; 1986; 36(2):349-55. PubMed ID: 3961012 [TBL] [Abstract][Full Text] [Related]
4. Gene expression analyses in cynomolgus monkeys provides mechanistic insight into high-density lipoprotein-cholesterol reduction by androgens in primates. Nantermet P; Harada S; Liu Y; Cheng S; Johnson C; Yu Y; Kimme D; Holder D; Hodor P; Phillips R; Ray WJ Endocrinology; 2008 Apr; 149(4):1551-61. PubMed ID: 18187556 [TBL] [Abstract][Full Text] [Related]
5. Long-term sustained delivery of androgens by means of TCPL devices and the effect on high-density lipoprotein in castrated rams. Benghuzzi HA; England BG Biomed Sci Instrum; 1995; 31():165-70. PubMed ID: 7654956 [TBL] [Abstract][Full Text] [Related]
6. Estradiol and high-dose dihydrotestosterone treatment causes changes in cynomolgus monkey prostate volume and histology identical to those caused by testosterone alone. Kamischke A; Weinbauer GF; Semjonow A; Lerchl A; Richter KD; Nieschlag E J Androl; 1999; 20(5):601-10. PubMed ID: 10520572 [TBL] [Abstract][Full Text] [Related]
7. Effect of inhibiting 5 alpha-reductase activity on the ability of testosterone to inhibit luteinizing hormone release in male sheep. Hileman SM; Lubbers LS; Kuehl DE; Schaeffer DJ; Rhodes L; Jackson GL Biol Reprod; 1994 Jun; 50(6):1244-50. PubMed ID: 8080913 [TBL] [Abstract][Full Text] [Related]
8. Dietary polyunsaturated fat modifies low-density lipoproteins and reduces atherosclerosis of nonhuman primates with high and low diet responsiveness. Rudel LL; Johnson FL; Sawyer JK; Wilson MS; Parks JS Am J Clin Nutr; 1995 Aug; 62(2):463S-470S. PubMed ID: 7625361 [TBL] [Abstract][Full Text] [Related]
9. The androgen control of sebum production. Studies of subjects with dihydrotestosterone deficiency and complete androgen insensitivity. Imperato-McGinley J; Gautier T; Cai LQ; Yee B; Epstein J; Pochi P J Clin Endocrinol Metab; 1993 Feb; 76(2):524-8. PubMed ID: 8381804 [TBL] [Abstract][Full Text] [Related]
10. The effects of testosterone on lipids and eicosanoids in cynomolgus monkeys. Weyrich AS; Rejeski WJ; Brubaker PH; Parks JS Med Sci Sports Exerc; 1992 Mar; 24(3):333-8. PubMed ID: 1549028 [TBL] [Abstract][Full Text] [Related]
11. Plasma lipoprotein profile in the male cynomolgus monkey under normal, hypogonadal, and combined androgen blockade conditions. Leblanc M; Bélanger MC; Julien P; Tchernof A; Labrie C; Bélanger A; Labrie F J Clin Endocrinol Metab; 2004 Apr; 89(4):1849-57. PubMed ID: 15070955 [TBL] [Abstract][Full Text] [Related]
12. Hair growth effects of oral administration of finasteride, a steroid 5 alpha-reductase inhibitor, alone and in combination with topical minoxidil in the balding stumptail macaque. Diani AR; Mulholland MJ; Shull KL; Kubicek MF; Johnson GA; Schostarez HJ; Brunden MN; Buhl AE J Clin Endocrinol Metab; 1992 Feb; 74(2):345-50. PubMed ID: 1309834 [TBL] [Abstract][Full Text] [Related]
13. The effect of 4MA, a potent inhibitor of 5 alpha-reductase, on the growth of androgen-responsive human genitourinary tumors grown in athymic nude mice. Andriole GL; Rittmaster RS; Loriaux DL; Kish ML; Linehan WM Prostate; 1987; 10(3):189-97. PubMed ID: 3588410 [TBL] [Abstract][Full Text] [Related]
14. Relationships of serum lipoproteins and apoproteins to sex hormones and to the binding capacity of sex hormone binding globulin in healthy Finnish men. Hämäläinen E; Adlercreutz H; Ehnholm C; Puska P Metabolism; 1986 Jun; 35(6):535-41. PubMed ID: 3086660 [TBL] [Abstract][Full Text] [Related]
15. Effects of finasteride (MK-906), a 5 alpha-reductase inhibitor, on circulating androgens in male volunteers. Gormley GJ; Stoner E; Rittmaster RS; Gregg H; Thompson DL; Lasseter KC; Vlasses PH; Stein EA J Clin Endocrinol Metab; 1990 Apr; 70(4):1136-41. PubMed ID: 2156887 [TBL] [Abstract][Full Text] [Related]
16. Comparison between testosterone enanthate-induced azoospermia and oligozoospermia in a male contraceptive study. III. Higher 5 alpha-reductase activity in oligozoospermic men administered supraphysiological doses of testosterone. Anderson RA; Wallace AM; Wu FC J Clin Endocrinol Metab; 1996 Mar; 81(3):902-8. PubMed ID: 8772548 [TBL] [Abstract][Full Text] [Related]
17. Effects of aromatase inhibition and androgen activity on serotonin and behavior in male macaques. Bethea CL; Reddy AP; Robertson N; Coleman K Behav Neurosci; 2013 Jun; 127(3):400-14. PubMed ID: 23506438 [TBL] [Abstract][Full Text] [Related]
18. MK-386, an inhibitor of 5alpha-reductase type 1, reduces dihydrotestosterone concentrations in serum and sebum without affecting dihydrotestosterone concentrations in semen. Schwartz JI; Tanaka WK; Wang DZ; Ebel DL; Geissler LA; Dallob A; Hafkin B; Gertz BJ J Clin Endocrinol Metab; 1997 May; 82(5):1373-7. PubMed ID: 9141518 [TBL] [Abstract][Full Text] [Related]
19. Testosterone prevents complete suppression of spermatogenesis in the gonadotropin-releasing hormone antagonist-treated nonhuman primate (Macaca fascicularis). Weinbauer GF; Göckeler E; Nieschlag E J Clin Endocrinol Metab; 1988 Aug; 67(2):284-90. PubMed ID: 3292557 [TBL] [Abstract][Full Text] [Related]
20. Interrelationships among lipoprotein levels, sex hormones, anthropometric parameters, and age in hypogonadal men treated for 1 year with a permeation-enhanced testosterone transdermal system. Dobs AS; Bachorik PS; Arver S; Meikle AW; Sanders SW; Caramelli KE; Mazer NA J Clin Endocrinol Metab; 2001 Mar; 86(3):1026-33. PubMed ID: 11238481 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]